Our fully integrated GxP services are driven by your assay requirements and delivered by our veteran scientists – collaboratively, accurately, and on time.
Biomarkers
Immunogenicity
Pharmacokinetics (PK)
Cell-Based Assays
Our team is comprised of recognized experts in effectively navigating complex and evolving opportunities for biotherapeutics innovation.
Biosimilars
Gene Therapy
Antibody Drug Conjugates (ADCs)
Immuno-oncology
14 November 2018 | 15:00 GMT / 10:00 EST | Co-Hosted with Bioanalysis Zone
Methods for the detection of drug-induced antibodies have become much more sensitive, but the question remains to be answered: are antibodies at this low concentration level clinically relevant? BioAgilytix Europe’s Dr. Arno Kromminga will be addressing this subject and more.
Explore the BioAgilytix way of thinking. Visit our Resource Center to learn more about our scientists’ expertise through case studies, blogs, industry articles and other scientific resources.
Quick links to our latest content offerings:
LinkedIn Company Updates
1 Day Agoview on linkedin
It’s not too late! There’s still time to register for the #webinar with Dr. Arno Kromminga happening tomorrow. Don’t miss this opportunity to hear from a true immunogenicity expert on the clinical relevance of (unwanted drug-induced) immune responses: https://lnkd.in/e6Cetcb
2 Days Agoview on linkedin
Pre-register for a dedicated time to have a one-on-one discussion with any of BioAgilytix Europe’s attending scientists during the EBF 11th Open Symposium, happening 21-23 November in Barcelona. Request a time to talk: https://lnkd.in/ePSUZGz
2 Days Agoview on linkedin
Join the BioAgilytix team in Durham, NC as a Study Coordinator to facilitate study administration and client communications that help meaningful drug development projects move forward. Learn more about the position here: https://lnkd.in/euPK5C7
November 9, 2018BioAgilytix Team Q&A: Meet Stuart Logan, Business Development Manager at BioAgilytix Europe
October 23, 2018Webinar Sneak Peek: Clinical Relevance of (Unwanted Drug-Induced) Immune Responses
November 2, 2018BioAgilytix to be Acquired by Private Investment Company Cobepa
October 3, 2018BioAgilytix Recognized as a Triangle Business Journal 2018 Fast 50 Winner
May 9, 2018Evaluating the Immunogenicity of Antibody–drug Conjugates
April 16, 2018Strategies for Development and Validation of Neutralizing Antibody Assays Supporting Biosimilars
Services
Platforms
Choose a Location to learn more about the premier bioanalytical services and solutions available at each of our advanced laboratories in the USA and Europe.
